| Literature DB >> 16571131 |
Mark N Prichard1, Debra C Quenelle, Deborah J Bidanset, Gloria Komazin, Sunwen Chou, John C Drach, Earl R Kern.
Abstract
Inhibition of the human cytomegalovirus UL97 kinase by maribavir is thought to be responsible for the antiviral activity of this compound. Some mutations that confer resistance to maribavir map to UL97, however additional mutations that also confer resistance to the drug were mapped to UL27. These open reading frames share a low level of homology, yet the function of pUL27 remains unknown. A recombinant virus with a deletion in the UL27 open reading frame was reported previously to exhibit a slight replication deficit, but a more important function in vivo was hypothesized given its homology to the UL97 kinase. The potential for an important function in vivo was investigated by determining if these knockout viruses could replicate in human tissue implanted in SCID mice. None of the AD169 derived viruses replicated well in the implanted thymus/liver tissue, and is consistent with previous observations, although all of the viruses replicated to some degree in retinal tissue implants. Replication of the parent viruses was observed at 7 days post inoculation, whereas no replication was detected with any of the recombinant viruses with deletions in UL27. By day 14, replication was detected in two of the three knockout viruses and in all of the viruses by day 42. These data are consistent with minimal defects observed in cell culture, but are not consistent with an important role for UL27 in vivo. We conclude that UL27 is not required for viral replication in vivo.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16571131 PMCID: PMC1448171 DOI: 10.1186/1743-422X-3-18
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Replication of UL27 deletion mutants in retinal tissue implants in SCID-hu mice.
| Virus | Days post infection | |||
| 7 | 16 | 28 | 42 | |
| AD169 (ATCC)a | 3.0 ± 0.58 (4/12)b | 3.5 ± 1.3 (5/12) | 3.7 ± 0.87 (10/12) | 4.1 ± 1.1 (7/14) |
| T2092-1-1-7 | 0 ± 0 (0/12) | 0 ± 0 (0/12) | 0 ± 0 (0/12) | 3.1 ± 0.17 (4/12) |
| AD169 RVc | 2.6 ± 0.17 (4/12) | 3.6 ± 1.2 (7/12) | 3.1 ± 0.52 (4/12) | 3.2 ± 0.74 (3/14) |
| ΔUL27BAC | 0 ± 0 (0/12) | 3.6 ± 0.87 (5/12) | 3.0 ± 0.45 (5/12) | 3.4 ± 0.61 (5/14) |
| 1/3ΔUL27BAC | 0 ± 0 (0/12) | 2.6 ± 0.21 (2/12) | 3.5 ± 0.04 (3/12) | 3.6 ± 0.52 (6/14) |
a. AD169 (ATCC) is the isogenic strain of AD169 for T2092-1-1-7.
b. Number shown is the average titer in units of log10PFU/g of tissue ± the standard deviation with the number of positive animals/the number of inoculated animals shown in parentheses.
c. AD169 RV is the isogenic strain of AD169 for UL27Δ and UL27Δ1/3.